Showing 3231-3240 of 7015 results for "".
What to Know About a State-of-the-Art Approach to GIST Treatment
https://reachmd.com/programs/medical-breakthroughs-from-penn-medicine/what-to-know-about-a-state-of-the-art-approach-to-gist-treatment/9949/Ronald DeMatteo, MD, of Penn Medicine talks about diagnosis, treatment and research for the rare Gastrointestinal Stromal Tumor (GIST).Targeting Neutrophilic Inflammation in Bronchiectasis: An Emerging Approach
https://reachmd.com/programs/medical-industry-feature/targeting-neutrophilic-inflammation-in-bronchiectasis-an-emerging-approach/33184/TBDPain and Physical Function Improve after Weight-Loss Surgery
https://reachmd.com/programs/the-jama-report/pain-and-physical-function-improve-after-weight-loss-surgery/8051/Among a group of patients with severe obesity who underwent bariatric surgery, a large percentage experienced improvement in pain.New Treatment for Advanced Melanoma Shows Promise
https://reachmd.com/programs/the-jama-report/new-treatment-advanced-melanoma-shows-promise/8066/Researchers from UCLA studied tumor response and overall survival following the administration of a new treatment for patients with advanced melanoma.Is it Asthma, COPD, or Bronchiectasis?
https://reachmd.com/programs/clinicians-roundtable/Asthma-COPD-or-bronchiectasis/54212/Distinguishing between asthma, COPD, and bronchiectasis can be challenging, as overlapping symptoms and mixed disease features often blur diagnostic lines. Tune in to hear Dr. Geoffrey Chupp discuss how clinicians can navigate this complexity and personalize treatment based on each patient’s underlyRethinking Anti-Aging
https://reachmd.com/topics/regenerative-medicine/rethinking-anti-aging/48724/Cellular longevity and the role of mTOR in skin health.Optimizing Hyperkalemia Management: Clinical Implications and Risk Assessment
https://reachmd.com/programs/cme/tbd/37670/Learn from a multidisciplinary faculty panel how to Improve outcomes for patients with CKD and HFrEF using optimal RAASi and MRAs while managing hyperkalemia with potassium binders.Case Application: Unlocking Relapsed/Refractory Myeloma With CELMoDs
https://reachmd.com/programs/cme/case-application-unlocking-relapsedrefractory-myeloma-with-celmods/36574/Beyond the Horizon in Multiple Myeloma: Harnessing Novel CELMoD Mechanisms for Increased Antimyeloma ActivityBreaking Barriers in AML: Risk Stratification, Molecular Profiling, and Novel Menin-Directed Treatment Options
https://reachmd.com/programs/cme/breaking-barriers-in-aml-risk-stratification-molecular-profiling-and-novel-menin-directed-treatment-options/33175/Explore advances in AML that integrate risk stratification, molecular profiling, and menin-targeted therapies to optimize care and improve outcomes.Amyloid-Targeted Therapies: A New Era in Alzheimer’s Disease Treatment
https://reachmd.com/programs/neurofrontiers/amyloid-targeted-therapies-a-new-era-in-alzheimers-disease-treatment/29278/Explore the latest amyloid-targeted therapies and how they might lead to a multifaceted treatment approach for Alzheimer's disease.